Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002131577 | SCV002460142 | likely benign | Birt-Hogg-Dube syndrome | 2024-11-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003308013 | SCV003999481 | likely benign | Hereditary cancer-predisposing syndrome | 2023-04-18 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV004999664 | SCV005623391 | uncertain significance | not provided | 2024-01-25 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV005248494 | SCV005896460 | benign | Birt-Hogg-Dube syndrome 1 | 2024-10-23 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |